Kenneth Allen Myszkowski, CFO at Arrowhead Pharmaceuticals, holds 400.60K shares in Arrowhead Pharmaceuticals (Ticker: ARWR). Most recently, Kenneth Allen Myszkowski Sold $40,000 shares of Arrowhead Pharmaceuticals on Mar 08, 2024 for an estimated value of 1.41M.